Teleflex
TFX
#3038
Rank
HK$41.29 B
Marketcap
HK$974.58
Share price
-0.23%
Change (1 day)
-2.49%
Change (1 year)
Categories
Teleflex Incorporated, is an American company providing specialty medical devices for a range of procedures in critical care and surgery.

P/E ratio for Teleflex (TFX)

P/E ratio as of October 2026 (TTM): -5.33

According to Teleflex's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -5.33462. At the end of 2025 the company had a P/E ratio of -5.94.

P/E ratio history for Teleflex from 2001 to 2026

PE ratio at the end of each year

Year P/E ratio Change
2025-5.94-104.88%
2024122275.54%
202332.42.74%
202231.62.21%
202130.9-44.23%
202055.451.86%
201936.5-35.73%
201856.7-19.58%
201770.5151.97%
201628.032.69%
201521.1
201323.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
29.4-650.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Abiomed
ABMD
64.8-1,314.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
50.8-1,051.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
17.0-417.77%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
35.7-769.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Cooper Companies
COO
18.5-446.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merit Medical
MMSI
34.8-752.27%๐Ÿ‡บ๐Ÿ‡ธ USA
AngioDynamics
ANGO
-12.9 141.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Integra LifeSciences
IART
-142 2,555.58%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.